AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Neoplasms

Interventions

DRUG

OMBRABULIN (AVE8062)

Dose escalation study with combination chemotherapy

Trial Locations (3)

Investigational Site Number 756001, Bellinzona

Investigational Site Number 380001, Milan

Investigational Site Number 250001, Villejuif